Journal article
The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2
DJ Scott, K Johan Rosengren, RAD Bathgate
Molecular Endocrinology | OXFORD UNIV PRESS INC | Published : 2012
DOI: 10.1210/me.2012-1188
Abstract
Relaxin and insulin-like peptide 3 (INSL3) are peptide hormones with a number of important physiological roles in reproduction, regulation of extracellular matrix turnover, and cardiovascular function. Relaxin and INSL3 mediate their actions through the closely related G-protein coupled receptors, relaxin family peptide receptors 1 and 2 (RXFP1 and RXFP2), respectively. These receptors have large extracellular domains (ECD) that contain high-affinity ligand-binding sites within their 10 leucine-rich repeat (LRR)-containing modules. Although relaxin can bind and activate both RXFP1 and RXFP2, INSL3 can only bind and activate RXFP2. To investigate whether this difference is related to the natu..
View full abstractRelated Projects (3)
Grants
Awarded by National Health and Medical Research Council (NHMRC)
Funding Acknowledgements
Studies at the Florey Neuroscience Institutes were supported by National Health and Medical Research Council (NHMRC) grants 454375 and 628427 and by the 's Operational Infrastructure Support Program. D.J.S. and R.A.D.B. are recipients of Australian NHMRC and C. J. Martin and Senior Research Fellowships, respectively. K.J.R. is a recipient of an NHMRC Career Development Award.